
Acalabrutinib Yields Similar Survival as Zanubrutinib in R/R CLL
Cancer Network,
Zanubrutinib and acalabrutinib produce similar safety profiles in the treatment of patients with relapsed/refractory chronic…
Zanubrutinib and acalabrutinib produce similar safety profiles in the treatment of patients with relapsed/refractory chronic…
Acalabrutinib and zanubrutinib demonstrated similar investigator-assessed progression-free survival in patients with relapsed/ref…
Abstract Background Delayed cancer diagnosis and inefficient cancer prognosis determination are problems faced in cancer…